VELIA
Velia is a biotech company that discovers and develops the therapeutic potential of human proteins.
VELIA
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.veliatx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Euro Google Maps CrUX Dataset CrUX Top 10m Google Maps Embed
Similar Organizations
Athersys
Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Formulatrix
Formulatrix is a biotechnology company that provides liquid handlers and protein crystallization automation solutions.
G.ST Antivirals
G.ST Antivirals focuses on the development of antiviral drugs.
Genentech
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients.
Padda Health
Padda Health is a Venture capital firm investing in healthcare startups.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Tridiuum
Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Key Employee Changes
| Date | New article |
|---|---|
| 2023-12-14 | Velia Therapeutics Appoints Michael York as Chief Business Officer |
Official Site Inspections
http://www.veliatx.com Semrush global rank: 12.07 M Semrush visits lastest month: 132
Unable to get host informations!!!
More informations about "Velia"
Velia | About Us - veliatx.com
Where most biotech companies find new approaches to drug known targets, Velia is uncovering novel biology. Our mission is to harness the therapeutic potential of a newly identified, yet abundant class of human proteins .See details»
Velia
Transformational work from Velia founders revealed that many previously overlooked peptides regulate biological functions vital to human health.See details»
John McHutchison, AO, MD - veliatx.com
During his ten years at Gilead, he led the organization in the successful filing of numerous New Drug Applications (NDAs) and supplemental label updates across multiple therapeutic areas, …See details»
Velia - Crunchbase Company Profile & Funding
Velia is a biotech company that discovers and develops the therapeutic potential of human proteins.See details»
Velia Therapeutics Company Profile | Management and ... - Datanyze
[email protected]: Velia Therapeutics Top Competitors. Company Employees Revenue Top technologies; Linera. 12: $2.5 M: ON Platform. 80: $16.8 M: Ampersand. 9: $3.1 M: Luca. …See details»
Velia 2025 Company Profile: Valuation, Funding
Velia General Information Description. Operator of a biotechnology Company intended to advance the development of targeted therapies. The company offers comprehensive genomic and proteomic data analysis, advanced …See details»
Velia Therapeutics - Overview, News & Similar companies
View Velia Therapeutics (www.veliatx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Velia - Products, Competitors, Financials, Employees, Headquarters ...
Veliatx.com. Overview & Products; Financials; People; Founded Year 2021. Stage Other Investors | Alive. About Velia. Velia is a biotechnology company focused on the discovery and …See details»
Velia Therapeutics Appoints Michael York as CBO
Dec 14, 2023 Led by an experienced management team and funded by top-tier venture groups, the company is poised to break new ground in protein-based therapeutics to transform medical …See details»
Velia Therapeutics Appoints Michael York as Chief Business Officer
Dec 14, 2023 Mr. York brings over 30 years of experience leading business development, strategic planning and commercial functions across pharmaceutical and biotech companiesSee details»
Velia | Our Science - veliatx.com
Targeting novel human proteins hidden in the genome. Velia’s purpose is to generate transformative therapeutics. We aim high: focusing on disease drivers - targets that will have the most significant impact on human health. Our …See details»
Velia on LinkedIn: Today, we announce that we are winding down ...
From South Korea to Germany, we're thrilled to announce that Olink will be at 23rd Human Proteome Organization World Congress (HUPO) again from October 20-24. Meet us at booth …See details»
Velia Therapeutics Names Alan Saghatelian, PhD, as Chief …
SAN DIEGO, August 12, 2024--Velia Therapeutics, a biotechnology company focused on the discovery and characterization of novel, disease relevant and druggable microproteins, today …See details»
Velia Therapeutics Appoints Michael York as Chief Business Officer
SAN DIEGO, Dec. 14, 2023 /PRNewswire/ -- Velia Therapeutics, a biotechnology company focused on the discovery and development of a new generation of protein-based therapeutics …See details»
Velia Therapeutics Announces Appointment of Veteran Drug …
Jul 19, 2023 Dr. McHutchison is a world-renowned physician, scientist, and drug developer who has led the research and development of numerous marketed therapies for chronic hepatitis B …See details»
Velia Therapeutics - Work in biotech
Velia is exploring previously overlooked peptides to create novel therapeutics. Peptides are an important class of biological molecules that regulate biological functions which are important …See details»
Velia Therapeutics
Harnessing the therapeutic potential of a novel class of human peptides. Transformational work from Velia founders revealed that many previously overlooked peptides regulate biological …See details»
Velia Therapeutics · GitHub
Veliatx/scrna_expression_atlas’s past year of commit activity. Jupyter Notebook 0 MIT 1 0 0 Updated Mar 3, 2025. proteomics_pipeline Public Proteomics pipeline to process mass spec …See details»
Velia Founders | Eric Olson, PhD - veliatx.com
Eric Olson is the founding chair of the Department of Molecular Biology at the University of Texas Southwestern Medical Center in Dallas. He holds the Robert A. Welch Distinguished Chair and …See details»
Michael York - veliatx.com
Michael began at Velia in November of 2023. He joined from Metacrine, where he served as CBO and subsequently CEO and completed license deals for the FXR portfolio and the HSD17B13 …See details»